William Sheridan - Concepedia

Author

William Sheridan

BioCryst Pharmaceuticals (United States)ORCID

Also Known As

Amanda Mathis, Chao A. Hsiung, Sheridan, William, W P Sheridan, W Sheridan, W. P. SHERIDAN, W. P. Sheridan, W. SHERIDAN, W. Sheridan, W.P Sheridan

146

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

BioCryst Pharmaceuticals (United States)The Royal Melbourne Hospital Amgen (United States)Ludwig Cancer Research Goethe University Frankfurt

About

William Sheridan is an author at BioCryst Pharmaceuticals (United States) specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	3.8K
2	Health Sciences	4	4	1.2K
3	Cell Biology	3	3	1.1K
4	Cellular Therapies	1	1	430
5	Clinical Nutrition	1	1	29

William Sheridan

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy William Sheridan, R. M. Fox, C. Glenn Begley, The Lancet Peripheral-blood Progenitor CellsThrombosisThrombopoiesisBlood PlateletMedicine	1992	879
EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY George Morstyn, John Keech, William Sheridan, The Lancet InflammationGranulocyteMedicineImmunologyHematology	1988	734
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430 Travis K. Warren, Jay Wells, Rekha G. Panchal, Nature Viral DiagnosticsViral PathogenesisImmunologyAntiviral Drug DevelopmentVirology	2014	597
GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION William Sheridan, M Wolf, Julie Lusk, The Lancet Cell TherapyTransplantationAutoimmune DiseaseMarrow TransplantationBone Marrow Failure	1989	430
Effects of Polyethylene Glycol–Conjugated Recombinant Human Megakaryocyte Growth and Development Factor on Platelet Counts after Chemotherapy for Lung Cancer Michael Fanucchi, John A. Glaspy, Jeffrey Crawford, New England Journal of Medicine	1997	293
Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers Laurence A. Harker, Lorin Roskos, Ulla M. Marzec, Blood	2000	219
Filgrastim in Patients with Chemotherapy-Induced Febrile Neutropenia: A Double-Blind, Placebo-Controlled Trial Graham J. Lieschke, M Wolf, William Sheridan, Annals of Internal Medicine	1994	195
Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia. Janet L. Nichol, Martha Hokom, A Hornkohl, Journal of Clinical Investigation Megakaryocyte GrowthImmunologyPathologyCell ProliferationInflammation	1995	187
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. George Morstyn, Lynda J. Campbell, Graham J. Lieschke, Journal of Clinical Oncology ImmunologyPharmacotherapyMetronomic ChemotherapyDermatologyImmunotherapy	1989	178
Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model Justin G. Julander, Venkatraman Siddharthan, J. T. Evans, Antiviral Research PathogenesisViral PathogenesisAntiviral Drug DevelopmentAntiviral TherapyVirology	2016	159

Page 1